Patterns of Patient Care in Appalachia

阿巴拉契亚地区的病人护理模式

基本信息

项目摘要

DESCRIPTION (provided by applicant): The rugged topography of the Appalachian Mountains geographically delineates the diverse region known as Appalachia. Most counties within Appalachia are designated as medically underserved, have sparse health care resources and lack integrated care systems, though a few highly urbanized, more prosperous areas found within or near the borders of Appalachia. We believe that a general lack of proximity to comprehensive medical services is associated with the recently reported excess cancer incidence and mortality in Appalachia, though no studies have systematically examined cancer treatment patterns, such as underuse of therapies and gaps in care. This three-year study will document and describe patterns of care for female breast and colorectal cancers diagnosed in 2006-2008 from state cancer registry, census and Medicare claims data files for a large region of Appalachia. The study population will include all estimated (N=7,800) cases of female breast cancer and (N=8,700) cases of colorectal cancer cases in among residents of Appalachian counties of PA, OH, KY, and NC. Study data will be processed, supplemented and quality assured necessary to determine the proportion of cases receiving National Comprehensive Cancer Network (NCCN) guideline concordant care for breast and colorectal cancer. These results will be compared to estimated rates of breast and colorectal cancer care for the study states, separately and pooled. Regression analyses of Appalachia data will seek to identify patient, tumor, provider, and facility factors that contribute to significant variation in receipt of the guideline-concordant care for breast and colorectal cancers including: 1) Age, race, gender (colorectal cancer only), comorbidity status, and socioeconomic status as proxied by dual enrollment in Medicaid and the socioeconomic status of patient's census tract of residence, 2) Facility typology and provider characteristics; and 3) Travel time distance from patients residence to specific types of providers (e.g., high volume of cancer care, comprehensive treatment center and oncologist practice). The effects of differential distance to specific types of providers (e.g., high volume of cancer care, comprehensive cancer services) will be modeled as an instrumental variable that corrects for selective referral. Secondary aims include exploring patient, facility and provider characteristics associated with delays in treatment and access to new or leading therapies. Study findings will be disseminated to Appalachian communities, policy makers, health care providers and to the scientific community. PUBLIC HEALTH RELEVANCE: This study seeks to identify patient, tumor, provider, and facility factors that contribute to significant variation in receipt of the guideline-concordant care for approximately 15,000 breast and colorectal cancers in a large region of Appalachia. Study aims will focus on the contributions of : i) Age, race, gender (colorectal cancer only), comorbidity status, and socioeconomic status (ii) Travel time distance from patients residence to specific types of providers (e.g., high volume of cancer care, comprehensive treatment center and oncologist practice); and (iii) Facility volume, type, comprehensiveness and accredited status, and surgeon case volume, training status, and vintage.
描述(由申请人提供):阿巴拉契亚山脉的崎岖地形在地理上描绘了被称为阿巴拉契亚的多样化地区。阿巴拉契亚内的大多数县被指定为医疗服务不足,医疗保健资源稀少,缺乏综合保健系统,尽管在阿巴拉契亚边界内或附近发现了一些高度城市化,更繁荣的地区。我们认为,普遍缺乏接近全面的医疗服务是与最近报道的过高的癌症发病率和死亡率在阿巴拉契亚,虽然没有研究系统地检查癌症治疗模式,如治疗不足和护理差距。这项为期三年的研究将记录和描述2006-2008年从阿巴拉契亚大片地区的州癌症登记处、人口普查和医疗保险索赔数据文件中诊断出的女性乳腺癌和结直肠癌的护理模式。研究人群将包括PA、OH、KY和NC的阿巴拉契亚县居民中的所有估计(N= 7,800)女性乳腺癌病例和(N= 8,700)结直肠癌病例。将对研究数据进行必要的处理、补充和质量保证,以确定接受国家综合癌症网络(NCCN)指南乳腺癌和结直肠癌协调治疗的病例比例。这些结果将与研究状态的乳腺癌和结直肠癌护理估计率进行比较,分别和汇总。对阿巴拉契亚数据的回归分析将寻求确定导致乳腺癌和结直肠癌指南一致性护理接受显著变化的患者、肿瘤、提供者和机构因素,包括:1)年龄、种族、性别(仅结直肠癌)、合并症状况和社会经济状况(由医疗补助中的双重登记和患者居住地人口普查区域的社会经济状况代表),2)设施类型和提供者特征;以及3)从患者住所到特定类型的提供者的旅行时间距离(例如,大量癌症护理、综合治疗中心和肿瘤学家实践)。与特定类型的提供者的距离不同的影响(例如,高容量的癌症护理、全面的癌症服务)将被建模为校正选择性转诊的工具变量。次要目的包括探索与治疗延迟和获得新的或领先的治疗方法相关的患者,设施和提供者特征。研究结果将分发给阿巴拉契亚社区,政策制定者,卫生保健提供者和科学界。 公共卫生相关性:本研究旨在确定患者、肿瘤、提供者和设施因素,这些因素导致阿巴拉契亚大区域约15,000例乳腺癌和结直肠癌接受指南一致性护理的显著差异。研究目的将集中在以下因素的贡献:i)年龄、种族、性别(仅结直肠癌)、合并症状态和社会经济状态(ii)从患者住所到特定类型的提供者(例如,高容量的癌症护理、综合治疗中心和肿瘤学家实践);以及(iii)设施容量、类型、综合性和认证状态,以及外科医生病例量、培训状态和年份。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roger T. Anderson其他文献

Quality of Life Evaluation in Chronic Lichen Sclerosus for Improved Medical Care
  • DOI:
    10.1177/009286159903300228
  • 发表时间:
    1999-12-30
  • 期刊:
  • 影响因子:
    1.900
  • 作者:
    Rukmini Rajagopalan;Roger T. Anderson;Elizabeth F. Sherertz;Libby Edwards
  • 通讯作者:
    Libby Edwards
Correction to: Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer
  • DOI:
    10.1245/s10434-021-10216-6
  • 发表时间:
    2021-05-22
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Shayna L. Showalter;Max O. Meneveau;Jessica Keim-Malpass;T. Fabian Camacho;Gabriella Squeo;Roger T. Anderson
  • 通讯作者:
    Roger T. Anderson
Description and evaluation of a faith community-based domestic violence pilot program in Forsyth County, NC
北卡罗来纳州福赛斯县基于信仰社区的家庭暴力试点计划的描述和评估
  • DOI:
    10.1300/j154v07n04_05
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Jones;T. S. Fowler;Deborah F. Farmer;Roger T. Anderson;David Richmond
  • 通讯作者:
    David Richmond
Effect of prescription benefit changes on medical care utilization in a Medicare HMO population.
处方福利变化对 Medicare HMO 人群医疗保健利用的影响。
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Rajesh Balkrishnan;Wesley G. Byerly;Fabian Camacho;Anshu Shrestha;Roger T. Anderson
  • 通讯作者:
    Roger T. Anderson
Language for Scholars: A Communication Skills Building Program
学者语言:沟通技能培养计划
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. Lybolt;Kate Gottfred;Roger T. Anderson;A. Olszewski
  • 通讯作者:
    A. Olszewski

Roger T. Anderson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roger T. Anderson', 18)}}的其他基金

Improving Uptake of Cervical Cancer Prevention Services in Appalachia
提高阿巴拉契亚地区宫颈癌预防服务的利用率
  • 批准号:
    10381628
  • 财政年份:
    2019
  • 资助金额:
    $ 45.89万
  • 项目类别:
Improving Uptake of Cervical Cancer Prevention Services in Appalachia
提高阿巴拉契亚地区宫颈癌预防服务的利用率
  • 批准号:
    10524229
  • 财政年份:
    2019
  • 资助金额:
    $ 45.89万
  • 项目类别:
Improving Uptake of Cervical Cancer Prevention Services in Appalachia
提高阿巴拉契亚地区宫颈癌预防服务的利用率
  • 批准号:
    10524070
  • 财政年份:
    2019
  • 资助金额:
    $ 45.89万
  • 项目类别:
Improving Uptake of Cervical Cancer Prevention Services in Appalachia
提高阿巴拉契亚地区宫颈癌预防服务的利用率
  • 批准号:
    9913491
  • 财政年份:
    2019
  • 资助金额:
    $ 45.89万
  • 项目类别:
Research Training and Educational Component (Component I) p370-385
研究培训和教育部分(第一部分)p370-385
  • 批准号:
    8737845
  • 财政年份:
    2014
  • 资助金额:
    $ 45.89万
  • 项目类别:
Research Training and Educational Component (Component I) p370-385
研究培训和教育部分(第一部分)p370-385
  • 批准号:
    8594392
  • 财政年份:
    2013
  • 资助金额:
    $ 45.89万
  • 项目类别:
Patterns of Patient Care in Appalachia
阿巴拉契亚地区的病人护理模式
  • 批准号:
    8096738
  • 财政年份:
    2010
  • 资助金额:
    $ 45.89万
  • 项目类别:
Patterns of Patient Care in Appalachia
阿巴拉契亚地区的病人护理模式
  • 批准号:
    8296023
  • 财政年份:
    2010
  • 资助金额:
    $ 45.89万
  • 项目类别:
RESEARCH ON OPTIMAL RECOVERY PRACTICES
最佳康复实践研究
  • 批准号:
    7607670
  • 财政年份:
    2007
  • 资助金额:
    $ 45.89万
  • 项目类别:
RESEARCH ON OPTIMAL RECOVERY PRACTICES
最佳康复实践研究
  • 批准号:
    7376669
  • 财政年份:
    2006
  • 资助金额:
    $ 45.89万
  • 项目类别:

相似海外基金

Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 45.89万
  • 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
  • 批准号:
    494901
  • 财政年份:
    2023
  • 资助金额:
    $ 45.89万
  • 项目类别:
    Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
  • 批准号:
    10714537
  • 财政年份:
    2023
  • 资助金额:
    $ 45.89万
  • 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
  • 批准号:
    10588103
  • 财政年份:
    2023
  • 资助金额:
    $ 45.89万
  • 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
  • 批准号:
    22K09407
  • 财政年份:
    2022
  • 资助金额:
    $ 45.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
  • 批准号:
    21KK0287
  • 财政年份:
    2022
  • 资助金额:
    $ 45.89万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
  • 批准号:
    10357120
  • 财政年份:
    2022
  • 资助金额:
    $ 45.89万
  • 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
  • 批准号:
    21K08700
  • 财政年份:
    2021
  • 资助金额:
    $ 45.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
  • 批准号:
    437315
  • 财政年份:
    2020
  • 资助金额:
    $ 45.89万
  • 项目类别:
    Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
  • 批准号:
    435603
  • 财政年份:
    2020
  • 资助金额:
    $ 45.89万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了